Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other Classes

E-ISSN： 2163-8306|4|8|445-453

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.8, 2015-08, pp. : 445-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Virus morphogenesis and viral entry as alternative targets for novel hepatitis C antivirals

By Chapel Cynthia Zitzmann Nicole Zoulim Fabien Durantel David

Future Virology, Vol. 1, Iss. 2, 2006-03 ,pp. : 197-209

Future Medicine

Access to resources Recommend Favorite

An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors

Current Medicinal Chemistry, Vol. 17, Iss. 11, 2010-04 ,pp. : 1067-1091

Bentham Science Publishers

Access to resources Recommend Favorite

Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

Blackwell Publishing

Access to resources Recommend Favorite

Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

Blackwell Publishing

Access to resources Recommend Favorite